Cargando…

Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses

A major limitation in the use of mouse models in breast cancer research is that most mice develop estrogen receptor‐alpha (ERα)‐negative mammary tumors, while in humans, the majority of breast cancers are ERα‐positive. Therefore, developing mouse models that best mimic the disease in humans is of fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Edmund Charles, Chattopadhyay, Mrittika, Gomez, Maria, Torre, Denis, Ma'ayan, Avi, Torres‐Martin, Miguel, Sia, Daniela, Germain, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577951/
https://www.ncbi.nlm.nih.gov/pubmed/36111352
http://dx.doi.org/10.1111/acel.13665
_version_ 1784811871023398912
author Jenkins, Edmund Charles
Chattopadhyay, Mrittika
Gomez, Maria
Torre, Denis
Ma'ayan, Avi
Torres‐Martin, Miguel
Sia, Daniela
Germain, Doris
author_facet Jenkins, Edmund Charles
Chattopadhyay, Mrittika
Gomez, Maria
Torre, Denis
Ma'ayan, Avi
Torres‐Martin, Miguel
Sia, Daniela
Germain, Doris
author_sort Jenkins, Edmund Charles
collection PubMed
description A major limitation in the use of mouse models in breast cancer research is that most mice develop estrogen receptor‐alpha (ERα)‐negative mammary tumors, while in humans, the majority of breast cancers are ERα‐positive. Therefore, developing mouse models that best mimic the disease in humans is of fundamental need. Here, using an inducible MMTV‐rtTA/TetO‐NeuNT mouse model, we show that despite being driven by the same oncogene, mammary tumors in young mice are ERα‐negative, while they are ERα‐positive in aged mice. To further elucidate the mechanisms for this observation, we performed RNAseq analysis and identified genes that are uniquely expressed in aged female‐derived mammary tumors. We found these genes to be involved in the activation of the ERα axis of the mitochondrial UPR and the ERα‐mediated regulation of XBP‐1s, a gene involved in the endoplasmic reticulum UPR. Collectively, our results indicate that aging alters the oncogenic trajectory towards the ERα‐positive subtype of breast cancers, and that mammary tumors in aged mice are characterized by the upregulation of multiple UPR stress responses regulated by the ERα.
format Online
Article
Text
id pubmed-9577951
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95779512022-10-19 Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses Jenkins, Edmund Charles Chattopadhyay, Mrittika Gomez, Maria Torre, Denis Ma'ayan, Avi Torres‐Martin, Miguel Sia, Daniela Germain, Doris Aging Cell Short Communication A major limitation in the use of mouse models in breast cancer research is that most mice develop estrogen receptor‐alpha (ERα)‐negative mammary tumors, while in humans, the majority of breast cancers are ERα‐positive. Therefore, developing mouse models that best mimic the disease in humans is of fundamental need. Here, using an inducible MMTV‐rtTA/TetO‐NeuNT mouse model, we show that despite being driven by the same oncogene, mammary tumors in young mice are ERα‐negative, while they are ERα‐positive in aged mice. To further elucidate the mechanisms for this observation, we performed RNAseq analysis and identified genes that are uniquely expressed in aged female‐derived mammary tumors. We found these genes to be involved in the activation of the ERα axis of the mitochondrial UPR and the ERα‐mediated regulation of XBP‐1s, a gene involved in the endoplasmic reticulum UPR. Collectively, our results indicate that aging alters the oncogenic trajectory towards the ERα‐positive subtype of breast cancers, and that mammary tumors in aged mice are characterized by the upregulation of multiple UPR stress responses regulated by the ERα. John Wiley and Sons Inc. 2022-09-15 2022-10 /pmc/articles/PMC9577951/ /pubmed/36111352 http://dx.doi.org/10.1111/acel.13665 Text en © 2022 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Jenkins, Edmund Charles
Chattopadhyay, Mrittika
Gomez, Maria
Torre, Denis
Ma'ayan, Avi
Torres‐Martin, Miguel
Sia, Daniela
Germain, Doris
Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title_full Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title_fullStr Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title_full_unstemmed Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title_short Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
title_sort age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577951/
https://www.ncbi.nlm.nih.gov/pubmed/36111352
http://dx.doi.org/10.1111/acel.13665
work_keys_str_mv AT jenkinsedmundcharles agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT chattopadhyaymrittika agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT gomezmaria agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT torredenis agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT maayanavi agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT torresmartinmiguel agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT siadaniela agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses
AT germaindoris agealterstheoncogenictrajectorytowardluminalmammarytumorsthatactivateunfoldedproteinsresponses